NCT05350800View on ClinicalTrials.gov

A Study to Evaluate the Drug Exposure of Single Ascending Doses of BMS-986369 and the Effect of Food on the BMS-986369 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

September 12, 2022

Primary Completion Date

May 4, 2023

Study Completion Date

May 4, 2023

Conditions
Healthy Volunteer
Interventions
DRUG

BMS-986369

Specified dose on specified days

Trial Locations (1)

33136

Local Institution - 0001, Miami

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT05350800 - A Study to Evaluate the Drug Exposure of Single Ascending Doses of BMS-986369 and the Effect of Food on the BMS-986369 in Healthy Participants | Biotech Hunter | Biotech Hunter